AEON Biopharma AEON
NYSE AEON
$0.23 +0.00 (+0.17%)
As of: Oct 20, 2026 · 2:39 PM EDT

AEON Biopharma (AEON) EBITDA (2022 - 2025)

Updated

AEON Biopharma's EBITDA was -$5.49 million in Q4 2025, compared with -$2.3 million a year earlier.

Analysis

AEON Biopharma (AEON) EBITDA (2022 - 2025) Analysis & Trends

For FY2025, EBITDA at AEON Biopharma came in at -$12.73 million.

  • In earlier years, EBITDA was $73.08 million in FY2024, -$318.4 million in FY2023 and -$48.36 million in FY2022.
  • The Q4 2025 figure marks the lowest quarterly EBITDA since Q1 2024.
  • Per Business Quant data, AEON's EBITDA in the three quarters before Q4 2025 was -$2.47 million (Q3 2025), -$4.32 million (Q2 2025) and -$443,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,145.01 Bn 1,113.60 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 623.28 Bn 541.80 Bn 17.26 Bn 9.10 Bn
3 AbbVie 511.45 Bn 484.57 Bn 12.70 Bn 8.33 Bn
4 Merck 366.08 Bn 320.46 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 297.44 Bn 261.43 Bn 11.24 Bn -
6 Astrazeneca 261.24 Bn 234.92 Bn 12.86 Bn 5.09 Bn
7 Amgen 234.78 Bn 190.17 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn -9.70 Bn
9 Pfizer 172.02 Bn 118.67 Bn 10.94 Bn 5.89 Bn
10 AEON Biopharma 11.69 Mn -9.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -5.49 Mn
Sep 30, 2025 -2.47 Mn
Jun 30, 2025 -4.32 Mn
Mar 31, 2025 -443,000.00
Dec 31, 2024 -2.30 Mn
Jun 30, 2024 153.50 Mn
Mar 31, 2024 -74.13 Mn
Sep 30, 2023 -283.69 Mn
Mar 31, 2023 -13.02 Mn
Dec 31, 2022 -15.00 Mn
API Access

AEON Biopharma EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=AEON&period=max&api_key=YOUR_API_KEY